Hims & Hers Health stock is trading -39.24% below its average target price of $44.82 after marking a 1.0% during today's morning session. Analysts are giving the Mid-Cap Medical and Nursing Services company an average rating of hold and target prices ranging from $22.0 to $85.0 per share.
The stock has an unusually large proportion of its shares sold short at 29.5%, and a short ratio of 2.53. Since 11.3% of the company's shares are owned by insiders, we can infer that there is a degree of alignment between management and shareholder interests. Finally, we also note that an average number of institutional investors are invested in the stock, with 79.1% of Hims & Hers Health's shares being owned by this investor type.
Institutions Invested in Hims & Hers Health
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2024-12-31 | Blackrock Inc. | 14% | 30,107,523 | $819,827,837 |
| 2024-12-31 | Vanguard Group Inc | 9% | 20,257,116 | $551,601,259 |
| 2024-12-31 | Farallon Capital Management LLC | 4% | 8,377,000 | $228,105,706 |
| 2024-12-31 | State Street Corporation | 4% | 7,772,923 | $211,656,689 |
| 2024-12-31 | Renaissance Technologies, LLC | 3% | 6,951,152 | $189,279,865 |
| 2024-12-31 | Arrowstreet Capital, Limited Partnership | 3% | 6,304,202 | $171,663,417 |
| 2024-12-31 | Goldman Sachs Group Inc | 3% | 5,543,668 | $150,954,077 |
| 2024-12-31 | Geode Capital Management, LLC | 2% | 4,329,996 | $117,905,789 |
| 2024-12-31 | Morgan Stanley | 2% | 4,028,991 | $109,709,423 |
| 2024-12-31 | Wellington Management Group, LLP | 2% | 3,422,566 | $93,196,470 |
Besides an analyst consensus of strong upside potential, other market factors point to there being mixed market sentiment on Hims & Hers Health.
